Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss causes stress and affects mental health; treatment and support needed.

Hair pain is more common in women with hair loss, but it's not linked to the cause or severity of hair loss.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

Hura crepitans and its compound daphne factor F3 may help treat hair loss by blocking a specific hair growth inhibitor.

Tianeptine, an antidepressant, may prevent stress-induced hair loss in mice.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Miscanthus sinensis flower extract may help promote hair growth and prevent hair loss.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

Stress does not greatly speed up aging or hair loss in politicians.

Trichodynia is a painful scalp condition not directly linked to the amount or type of hair loss and may involve psychological factors, with treatments showing mixed results.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Reassurance and counseling are key in managing acute telogen effluvium, with supplements possibly offering a placebo effect.

The study suggests pandemic stress might worsen or trigger hair loss problems.

Green tea compounds significantly increased hair regrowth in some mice.

Lifestyle choices like stress, smoking, heavy drinking, sun exposure, and chemical hair treatments might speed up hair loss in people with androgenetic alopecia.

New treatments for hair loss are promising.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

COVID-19 infection can significantly cause temporary hair loss.

The document concludes that a new treatment for a type of hair loss called telogen effluvium was tested and shows promise.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.